identifier: NCT01105650) enrolled 14 ovarian cancer patients, which were infused with haploidentical IL-2 activated NK cells followed by SC IL-2 infusion three times per week for fourteen days, after which NK cell expansion was detected in the peripheral blood of patients [79]. This evidence concerns the gene IL2 and ovarian carcinoma.